Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Neuroprotective microtubule polymerizing agent set for clinical development

Aug. 4, 2004

Spotlight on glycogen synthase kinase-3

Aug. 4, 2004

Uridine prodrug shows beneficial effects in models of Alzheimer's disease, hypoxia, oxidative stress

Aug. 3, 2004

New GPR-88 inhibitors and their use in depression, rhythm disorders, etc.

Aug. 3, 2004

Pramipexole and levodopa confer benefit to Parkinson's disease patients

Aug. 2, 2004

Celera Diagnostics and Merck & Co. enter Alzheimer's collaboration

Aug. 2, 2004

Acorda Therapeutics acquires Zanaflex rights from Elan

Aug. 2, 2004

New monoamine reuptake inhibitors discovered by Lilly researchers

Aug. 2, 2004

Ecgonine and ecgonidine analogues and their use reported by Entropin

Aug. 2, 2004

New data on mild cognitive impairment and its relationship with Alzheimer's disease

Aug. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...